1Bach F,Uddin FJ,Burke D.Angiopoietins in malignancy[J].Eur J Surg Oncol,2007;33(1):7-15.
2Sonja L,Henning C,Uta R,et al.Determination of microvessel density by quantitative real-time PCR in esophageal cancer:correlation with histologic methods,angiogenic growth factor expression,and lymph node metastasis[J].Clin Cancer Res,2007;13(1):76-80.
3Li LY,Barlow KD,Metheny-Barlow LJ.Angiopoietins and Tie2 in health and disease[J].Pediatr Endocrinol Rev,2005;2(3):399-408.
5Kuboki S,Shimizu H,Mitsuhashi N,et al.Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma[J].Gastroenterol Hepatol,2008;23(2):157-64.
6Tsutsui S,Inoue H,Yasuda K,et al.Angiopoietin-2 expression in invasive ductal carcinoma of the breast:its relationship to the VEGF expression and microvessel density[J].Breast Cancer Res Treat,2006;98(3):261-6.
7Seval Y,Sati L,Celik-Ozenci C,et al.The distribution of angiopoietin-1,angiopoietin-2 and their receptors Tie-1 and Tie-2 in the very early human placenta[J].Placenta,2008;29(9):809-15.
1McNamara DA, Harmcy JH, Walsh TN, et al. Significance of angiogenesis in cancer therapy[J]. Br J Surg, 1998 ;85 : 1044-55.
2Bussolino F, Mantovani A, Persico G, et al. Molecular Mechanisms of blood vessel formation [ J]. Trends Biochem Sci, 1997 ;22:251-6.
3Harmey JH, Dimitriadis E, Kay E, et al. Regulation of macrophage production of vascular endothelial growth factor ( VEGF ) by hypoxia and transforming growth factor beta-1 [ J ]. Ann Surg Oncol, 1998 ;5:271-8.
4Sauter ER, Nesbit M, Watson JC, et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squaous cell carcinomas of the head and neck[ J]. Clin Cancer Res, 1999 ;5:775-8.
5Takahashi T, Shibuya M. The 230Kda Mature form of KDR/FLK-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mito signals in NIH3H3 fibroblasts [ J]. Oneogene, 1997 ; 14 : 2079 -89.
6Kroll J, Waltenberger J. Regulation of the endothelial function and angiogenesis by endothelial growth factor-A ( VEGF-A ) [ J ]. Z Kardiol, 2000 ;89:206-18.
7Semenza GL, Expression of hypoxia-inducible factor 1 : mechanisms and consequences[ J]. Biochem Pharmacol,2000 ;59:47-53.
8Sanchez-Elsner T, Botella LM, Velasco B, et al. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression [ J ]. JBC, 2001 ; 276 : 38527-35.
3Gelareh Z, Keyvan K, Qian B, et al. Role of angiopoietin-2 in regulating growth and vascularity of astrocytomas[ J]. J Onco1,2010 ;2 ( 1 ) :1-7.
4Jo MJ, Lee JH, Nam BH. Preoperative serum angiopoietin-2 levels con'elate with lymph node status in patients with early gastric cancer[ J]. Ann Surg Onco1,2009 ; 16 ( 7 ) :2052-7.
5Sallinen H, Heikura T, Laidinen S, et al. Preoperative angiopoietin-2 serum levels : a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer[ J ]. Int J Gynecol Cancer, 2010 ;20 (9) :1498-505.
6Ozuysal S, Bilgin T, Ozgur T. Expression of eyclooxygenase-2 in ovarian serous carcinoma : correlation with angiogenesis, rim23 expression and survival[J]. Eur J Gynaecol Oncol, 2009 ;30(6) :640-5.
7Takatori H, Natsugoe S, Okumura H,et al. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma [J]. Eur J Surg Onco1,2008 ;34 (4) :397-402.
8Coffeh SB,Tal AO,Scholz A. Angiopoietin-2 regulates gene expression in tie-2-expressing monocytes and augments their inherent proangiogenic functions [ J]. Cancer Res,2010 ;70 ( 13 ) :5270-80.
9Atsushi Shiozaki,Monika Lodyga,Xiao-Hui Bai,Jeya Nadesalingam,Takeshi Oyaizu,Daniel Winer,Sylvia L. Asa,Shaf Keshavjee,Mingyao Liu.XB130, a Novel Adaptor Protein, Promotes Thyroid Tumor Growth[J]. The American Journal of Pathology . 2011 (1)
10Liu X,Wang S,Xia X,et al.Synergistic role between p53 and JWA:prognostic and predictive biomarkers in gastric cancer. PLoS One . 2012
